239 related articles for article (PubMed ID: 21328275)
1. Interventions for preventing neuropathy caused by cisplatin and related compounds.
Albers JW; Chaudhry V; Cavaletti G; Donehower RC
Cochrane Database Syst Rev; 2011 Feb; (2):CD005228. PubMed ID: 21328275
[TBL] [Abstract][Full Text] [Related]
2. Interventions for preventing neuropathy caused by cisplatin and related compounds.
Albers JW; Chaudhry V; Cavaletti G; Donehower RC
Cochrane Database Syst Rev; 2014 Mar; 2014(3):CD005228. PubMed ID: 24687190
[TBL] [Abstract][Full Text] [Related]
3. Interventions for preventing neuropathy caused by cisplatin and related compounds.
Albers J; Chaudhry V; Cavaletti G; Donehower R
Cochrane Database Syst Rev; 2007 Jan; (1):CD005228. PubMed ID: 17253547
[TBL] [Abstract][Full Text] [Related]
4. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
van As JW; van den Berg H; van Dalen EC
Cochrane Database Syst Rev; 2014 Jul; (7):CD009219. PubMed ID: 24984156
[TBL] [Abstract][Full Text] [Related]
5. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
van As JW; van den Berg H; van Dalen EC
Cochrane Database Syst Rev; 2012 May; (5):CD009219. PubMed ID: 22592737
[TBL] [Abstract][Full Text] [Related]
6. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
van As JW; van den Berg H; van Dalen EC
Cochrane Database Syst Rev; 2019 May; 5(5):CD009219. PubMed ID: 31063591
[TBL] [Abstract][Full Text] [Related]
7. Treatment for cryoglobulinemic and non-cryoglobulinemic peripheral neuropathy associated with hepatitis C virus infection.
Benstead TJ; Chalk CH; Parks NE
Cochrane Database Syst Rev; 2014 Dec; (12):CD010404. PubMed ID: 25525951
[TBL] [Abstract][Full Text] [Related]
8. Vitamin E neuroprotection for cisplatin neuropathy: a randomized, placebo-controlled trial.
Pace A; Giannarelli D; Galiè E; Savarese A; Carpano S; Della Giulia M; Pozzi A; Silvani A; Gaviani P; Scaioli V; Jandolo B; Bove L; Cognetti F
Neurology; 2010 Mar; 74(9):762-6. PubMed ID: 20194916
[TBL] [Abstract][Full Text] [Related]
9. Interventions for preventing oral mucositis for patients with cancer receiving treatment.
Worthington HV; Clarkson JE; Eden OB
Cochrane Database Syst Rev; 2006 Apr; (2):CD000978. PubMed ID: 16625538
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotection for treatment of glaucoma in adults.
Sena DF; Lindsley K
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD006539. PubMed ID: 28122126
[TBL] [Abstract][Full Text] [Related]
11. Early and late renal adverse effects after potentially nephrotoxic treatment for childhood cancer.
Knijnenburg SL; Mulder RL; Schouten-Van Meeteren AY; Bökenkamp A; Blufpand H; van Dulmen-den Broeder E; Veening MA; Kremer LC; Jaspers MW
Cochrane Database Syst Rev; 2013 Oct; (10):CD008944. PubMed ID: 24101439
[TBL] [Abstract][Full Text] [Related]
12. Interventions for preventing oral mucositis for patients with cancer receiving treatment.
Worthington HV; Clarkson JE; Eden OB
Cochrane Database Syst Rev; 2007 Oct; (4):CD000978. PubMed ID: 17943748
[TBL] [Abstract][Full Text] [Related]
13. Limited access trial using amifostine for protection against cisplatin- and three-hour paclitaxel-induced neurotoxicity: a phase II study of the Gynecologic Oncology Group.
Moore DH; Donnelly J; McGuire WP; Almadrones L; Cella DF; Herzog TJ; Waggoner SE;
J Clin Oncol; 2003 Nov; 21(22):4207-13. PubMed ID: 14615449
[TBL] [Abstract][Full Text] [Related]
14. Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.
Mahdi-Rogers M; Brassington R; Gunn AA; van Doorn PA; Hughes RA
Cochrane Database Syst Rev; 2017 May; 5(5):CD003280. PubMed ID: 28481421
[TBL] [Abstract][Full Text] [Related]
15. Oxcarbazepine for neuropathic pain.
Zhou M; Chen N; He L; Yang M; Zhu C; Wu F
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD007963. PubMed ID: 29199767
[TBL] [Abstract][Full Text] [Related]
16. Vitamin B for treating peripheral neuropathy.
Ang CD; Alviar MJ; Dans AL; Bautista-Velez GG; Villaruz-Sulit MV; Tan JJ; Co HU; Bautista MR; Roxas AA
Cochrane Database Syst Rev; 2008 Jul; (3):CD004573. PubMed ID: 18646107
[TBL] [Abstract][Full Text] [Related]
17. Interventions for preventing oral mucositis for patients with cancer receiving treatment.
Clarkson JE; Worthington HV; Eden OB
Cochrane Database Syst Rev; 2003; (3):CD000978. PubMed ID: 12917895
[TBL] [Abstract][Full Text] [Related]
18. Drug treatment for spinal muscular atrophy types II and III.
Wadman RI; Bosboom WM; van der Pol WL; van den Berg LH; Wokke JH; Iannaccone ST; Vrancken AF
Cochrane Database Syst Rev; 2012 Apr; (4):CD006282. PubMed ID: 22513940
[TBL] [Abstract][Full Text] [Related]
19. Drug treatment for spinal muscular atrophy types II and III.
Wadman RI; Bosboom WM; van den Berg LH; Wokke JH; Iannaccone ST; Vrancken AF
Cochrane Database Syst Rev; 2011 Dec; (12):CD006282. PubMed ID: 22161400
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of erythropoietin and its carbamylated derivative in experimental Cisplatin peripheral neurotoxicity.
Bianchi R; Brines M; Lauria G; Savino C; Gilardini A; Nicolini G; Rodriguez-Menendez V; Oggioni N; Canta A; Penza P; Lombardi R; Minoia C; Ronchi A; Cerami A; Ghezzi P; Cavaletti G
Clin Cancer Res; 2006 Apr; 12(8):2607-12. PubMed ID: 16638873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]